Recursion Pharmaceuticals, Inc.
RXRX • NASDAQ • Stock Fundamentals
Recursion Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Najat Khan, with a market cap of $1.7B.
Market Cap$1.7B
Employees500.0
CEONajat Khan
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Recursion Pharmaceuticals, Inc. FAQ
Common questions about Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. (RXRX) has a market capitalization of $1.7B and trades on NASDAQ.
Recursion Pharmaceuticals, Inc. has approximately 500 employees.